Computer-Aided Drug Discovery

Computer-aided drug design (CADD) is a widely used technology using computational tools and resources for the storage...

Home / Medicinal Chemistry / Computer-Aided Drug Discovery

Computer-Aided Drug Discovery

Computer-Aided Drug Discovery

Computer-aided drug design (CADD) is a widely used technology using computational tools and resources for the storage, management, analysis and modeling of compounds. It relies on digital repositories for the study of designing compounds with physicochemical characteristics, predicting whether a given molecule will be combined with the target, and if so how strongly. Computer-based methods can help us to search new hits in drug discovery, screening many irrelevant compounds at the same time and study the structure-activity relationship of drug molecules.

Computer-Aided Drug Discovery

The advantages of CADD

The traditional strategies for discovering new drug usually begin with taking a lead structure, and then develop a chemical program to find an analog molecule which can exhibit the desired biological properties. The process often involved a long cycle and a large number of experiments, in which medical chemist utilizing their experience and intuition to ultimately select a candidate for further development. The whole process is laborious, expensive and inelegant. Contrary to traditional drug design methods, CADD has been applied as a highly effective tool for systematic assessment of potential lead candidates before they are synthesized and tested. In this way, it saves time as well as cost in drug discovery.

Our Services

Molecule docking has become one of the most useful drug design approach, in which the 3-D structure of a binding site can be analyzed and leads to a comprehensive investigation of the interactions between drug and receptor. Docking study plays an important role in the QSAR methods and homology modeling, so it is useful in the structure-based drug design.

Virtual screening, a commonly used computational technique in the field of drug discovery, is often applied to identify the most valuable structures, which can bind to a drug target, in a wide array of small molecules. BOC Sciences mainly focus on the designing and optimizing targeted combinatorial libraries. Additionally, our experts is able to enrich those libraries of available compounds from in-house compound repositories or vendor offerings.

Activity prediction is an important part in our CADD services, in order to predict the selectivity and affinity of compounds against targets. In this service, a molecule may be expanded to a wide range of conformers, and then their affinities to targets will be analyzed by our comprehensive evaluation system.

As an integral part of rational drug design, Quantitative Structure Activity Relationships (QSAR) has been developed to quantitatively analysis the relationships between the chemical structural-related properties and biological activity or target property) of compounds being studied. Moreover, QSAR is also recommended as a useful tool to determine the parameters responsible for biological response which have an essential effect on the optimization of lead compound.

Physicochemical properties are key factors in controlling the interactions of xenobiotics with living organisms. Computational approaches to toxicity prediction generally rely to a very large extent on the physicochemical properties of the query compounds. Consequently the reliable silico methods are important for the rapid calculation of physicochemical properties.

Why are you working with us?

  • Industry-standard software and hardware
  • Proprietary design concepts and tools
  • An experienced scientist
  • A good track record of success
  • Close integration with related disciplines
  • Problem-solving expertise and creativity
  • Ability to execute patenting strategies

References

  1. Kapetanovic, I. M. (2008). Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chemico-biological interactions171(2), 165-176.
  2. Lu, P., Bevan, D. R., Leber, A., Hontecillas, R., Tubau-Juni, N., & Bassaganya-Riera, J. (2018). Computer-Aided Drug Discovery. Accelerated Path to Cures, 7-24.
Quote Request
Verification code